Ra Capital Management, L.P.

EDGAR CIK 0001346824

Tyra Biosciences, Inc. - TYRA

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$19.84 M
1,220,681 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/08/2024
11/13/2024
Buy
1,220,681 @ $16.25
 $19,836,066 8,697,956 (16.33%) Indirect - See footnotes

Janux Therapeutics, Inc. - JANX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$53.70 M
1,200,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/18/2024
10/22/2024
Buy
1,200,000 @ $44.75
 $53,700,000 9,317,246 (14.78%) Indirect - See footnotes

An2 Therapeutics, Inc. - ANTX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($3.81) M
-3,525,094 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/09/2024
08/13/2024
Sell
-3,525,094 @ $1.08
 ($3,807,102) 300,853 (-92.14%) Indirect - See footnotes

Climb Bio, Inc. - CLYM

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$49.95 M
13,008,546 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/27/2024
07/01/2024
Buy
13,008,546 @ $3.84
 $49,952,817 2,866,375 (-128.26%) Indirect - See footnotes

Aerovate Therapeutics, Inc. - AVTE

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$1.55 M
928,110 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/17/2024
06/20/2024
Buy
928,110 @ $1.67
 $1,549,944 7,893,678 (13.32%) Indirect - See footnotes

ARS Pharmaceuticals, Inc. - SPRY

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
3
$13.29 M
1,401,299 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/27/2024
03/27/2024
Buy
505,954 @ $9.79
 $4,953,290 9,958,073 (5.35%) Indirect - See footnotes
03/26/2024
03/27/2024
Buy
457,745 @ $9.55
 $4,371,465 9,452,119 (5.09%) Indirect - See footnotes
03/25/2024
03/27/2024
Buy
437,600 @ $9.06
 $3,964,656 8,994,374 (5.11%) Indirect - See footnotes

Nkarta, Inc. - NKTX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$30.00 M
3,000,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/27/2024
03/29/2024
Buy
3,000,000 @ $10.00
 $30,000,000 10,050,818 (42.55%) Indirect - See footnotes

LENZ Therapeutics, Inc. - LENZ

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$15.00 M
998,009 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/21/2024
03/25/2024
Buy
998,009 @ $15.03
 $15,000,075 694,755 (-329.10%) Indirect - See footnotes

89Bio, Inc. - ETNB

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$20.72 M
1,350,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/04/2024
03/06/2024
Buy
1,350,000 @ $15.35
 $20,722,500 12,431,584 (12.18%) Indirect - See Footnotes

Pepgen Inc. - PEPG

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$27.21 M
2,557,593 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/09/2024
02/13/2024
Buy
2,557,593 @ $10.64
 $27,212,790 9,179,273 (38.62%) Indirect - See footnotes

Solid Biosciences Inc. - SLDB

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$5.00 M
904,160 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/11/2024
01/12/2024
Buy
904,160 @ $5.53
 $5,000,005 4,192,216 (27.50%) Indirect - See footnotes